1
|
Dhillon P, Naidu M, Olson MC, VanBuren WM, Sheedy SP, Wells ML, Fidler JL, Heiken JP, Venkatesh SK, Kelm ZS. Diffusely Infiltrative Small Bowel Disease. Radiographics 2024; 44:e230148. [PMID: 39207924 DOI: 10.1148/rg.230148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/04/2024]
Abstract
Multiple infiltrative disorders can affect the small bowel, often resulting in diffuse small bowel wall thickening. These infiltrative disorders can manifest owing to various factors such as an influx of immunologic or neoplastic cells or the accumulation of substances within one or more layers of the intestinal wall. Although there can be considerable overlap in the appearances of infiltrative diseases on cross-sectional images, a comprehensive understanding of more specific ancillary imaging features and clinicopathologic correlation can substantially narrow the differential diagnosis. The radiologist can be instrumental in synthesizing the clinical and imaging information and guiding subsequent workup. The authors present a comprehensive review of the infiltrative disorders that commonly involve the small bowel. These disorders are organized on the basis of their pathophysiologic features, with multiple illustrative case examples to enhance understanding of these entities. CT and MRI are currently the most commonly used imaging modalities for evaluating small bowel disorders, and this review is focused on these two modalities. Detailed information regarding the pathologic features, clinical presentation, and imaging findings of these infiltrative disorders is provided to aid radiologists in recognizing and differentiating these conditions. ©RSNA, 2024.
Collapse
Affiliation(s)
- Preet Dhillon
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Madeline Naidu
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Michael C Olson
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Wendaline M VanBuren
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Shannon P Sheedy
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Michael L Wells
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Jeff L Fidler
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Jay P Heiken
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Sudhakar K Venkatesh
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| | - Zachary S Kelm
- From the Department of Radiology (P.D., M.C.O., W.M.V., S.P.S., M.L.W., J.L.F., J.P.H., S.K.V., Z.S.K.), Mayo Clinic (M.N.), 200 First St SW, Rochester, MN 55905
| |
Collapse
|
2
|
Gupta S, Allegretti JR. Mimics of Crohn's Disease. Gastroenterol Clin North Am 2022; 51:241-269. [PMID: 35595413 DOI: 10.1016/j.gtc.2021.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
Crohn's disease is a chronic inflammatory disease that can affect any portion of the gastrointestinal tract. Associated symptoms can vary based on the severity of disease, extent of involvement, presence of extraintestinal manifestations, and development of complications. Diagnosis is based on a constellation of findings. Many diseases can mimic Crohn's disease and lead to diagnostic conundrums. These include entities associated with the gastrointestinal luminal tract, vascular disease, autoimmune processes, various infections, malignancies and complications, drug- or treatment-induced conditions, and genetic diseases. Careful consideration of possible causes is necessary to establish the correct diagnosis.
Collapse
Affiliation(s)
- Sanchit Gupta
- Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, 850 Boyslton Street, Suite 201, Chestnut Hill, MA 02467, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
| | - Jessica R Allegretti
- Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, 850 Boyslton Street, Suite 201, Chestnut Hill, MA 02467, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
| |
Collapse
|
3
|
A Comprehensive Review of Infectious Granulomatous Diseases of the Gastrointestinal Tract. Gastroenterol Res Pract 2021; 2021:8167149. [PMID: 33628227 PMCID: PMC7886506 DOI: 10.1155/2021/8167149] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 01/01/2021] [Accepted: 01/28/2021] [Indexed: 12/21/2022] Open
Abstract
A granuloma is defined as a localized inflammatory reaction or a hypersensitive response to a nondegradable product leading to an organized collection of epithelioid histiocytes. Etiologies of granulomatous disorders can be divided into two broad categories: infectious and noninfectious (autoimmune conditions, toxins, etc.) causes. The endless list of causalities may prove challenging for gastroenterologists and pathologists to formulate a list of clearly defined differentials. This is true when distinguishing these etiologies based on various clinical presentations and endoscopic and histological findings. We aim to provide a comprehensive review of some of the frequent and rare infectious granulomatous diseases of the gastrointestinal tract documented in the literature to date. We provide an overview of each infectious pathology with an emphasis on epidemiology, clinical presentation, and endoscopic and histologic findings, in addition to treatment.
Collapse
|
4
|
Chee D, Moritz AW, Profit AP, Agarwal AN, Anstead GM. Fatal coccidioidomycosis involving the lungs, brain, tongue, and adrenals in a cirrhotic patient. An autopsy case. IDCases 2021; 23:e01049. [PMID: 33532240 PMCID: PMC7822947 DOI: 10.1016/j.idcr.2021.e01049] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Accepted: 01/12/2021] [Indexed: 12/17/2022] Open
Abstract
In this paper, we describe a case of fatal disseminated coccidioidomycosis (CM). The patient was a 44-year old male with a history of cirrhosis who presented with altered mental status, cough, and an enlarged, ulcerated tongue. On evaluation, the patient was found to have coccidioidal infection of the tongue, lungs, and brain. Despite over two months of antifungal treatment, the patient died from aspiration pneumonia and at autopsy was found to have persistent infection of the tongue and lungs, extensive mycosis of the brain, and involvement of both adrenal glands. The fulminant course of coccidioidomycosis in this patient is ascribed to his baseline cirrhosis and lymphocytopenia. There are few autopsy cases of CM that have been described in the post-antifungal era and few published cases of CM with either tongue or adrenal involvement.
Collapse
Affiliation(s)
- David Chee
- San Antonio Infectious Diseases Consultants, 8042 Wurzbach Road, San Antonio, TX, 78229, United States
| | - August W Moritz
- Methodist Hospital, 7700 Floyd Curl, San Antonio, TX, 78229, United States
| | - Amanda P Profit
- Medical City Dallas Hospital, 7777 Forest Ln, Suite A-200, Dallas, TX, 75230, United States
| | - Apeksha N Agarwal
- Department of Pathology, University of Texas Health, 7703 Floyd Curl Drive, San Antonio, TX, 78229, United States
| | - Gregory M Anstead
- Medical Service, Division of Infectious Diseases, South Texas Veterans Healthcare System, 7400 Merton Minter Blvd, San Antonio, TX, 78229, United States.,Department of Medicine, Division of Infectious Diseases, University of Texas Health, 7703 Floyd Curl Dr, San Antonio, TX, 78229, United States
| |
Collapse
|
5
|
Jenks JD, Reed SL, Hoenigl M. Risk factors and outcomes of culture-proven acute Coccidioides spp. infection in San Diego, California, United States. Mycoses 2020; 63:553-557. [PMID: 32176829 DOI: 10.1111/myc.13074] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2019] [Revised: 03/05/2020] [Accepted: 03/10/2020] [Indexed: 11/27/2022]
Abstract
BACKGROUND Coccidioides spp. are dimorphic fungi endemic to parts of the United States, Mexico, Central and South America. Infection can cause a range of disease from self-limited acute pneumonia to severe disseminated disease. METHODS We performed a retrospective chart review of medical records of cases of culture-proven acute coccidioidomycosis at the University of California San Diego between 1 April 2015 and 31 December 2019 and described the demographics, risk factors and outcomes of these cases. RESULTS Over the study period, fifteen evaluable cases of culture-proven acute coccidioidomycosis were identified. Of these, 87% (13/15) had traditional risk factors for coccidioidomycosis infection while two lacked known risk factors, including one patient with cirrhosis and one with chronic hepatitis C infection. Seven of fifteen (47%) had primary coccidioidomycosis of the lungs without dissemination and 7/15 (47%) disseminated disease. Of those with disseminated disease, 6/7 (86%) had either high-risk ethnicity or blood type as their only risk factor. At 90 days, 11/15 (73%) were alive, 3/15 (20%) deceased and 1/15 (7%) lost to follow-up. Of those not alive at 90 days, 1/3 (33%) had disseminated disease and 2/3 (67%) primary coccidioidomycosis, both on immunosuppressive therapy. DISCUSSION Coccidioides spp. infection occurs in a variety of hosts with varying underlying risk factors, with the majority in our cohort overall and 86% with disseminated disease lacking traditional risk factors for invasive fungal infection other than ethnicity and/or blood phenotype. Clinicians should be aware of these non-traditional risk factors in patients with coccidioidomycosis infection.
Collapse
Affiliation(s)
- Jeffrey D Jenks
- Department of Medicine, University of California San Diego, La Jolla, California.,Clinical and Translational Fungal - Working Group, University of California San Diego, La Jolla, California
| | - Sharon L Reed
- Clinical and Translational Fungal - Working Group, University of California San Diego, La Jolla, California.,Department of Pathology, University of California San Diego, La Jolla, California.,Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, California
| | - Martin Hoenigl
- Clinical and Translational Fungal - Working Group, University of California San Diego, La Jolla, California.,Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, California
| |
Collapse
|
6
|
Shivashankar R, Lichtenstein GR. Mimics of Inflammatory Bowel Disease. Inflamm Bowel Dis 2018; 24:2315-2321. [PMID: 29947781 DOI: 10.1093/ibd/izy168] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Indexed: 12/31/2022]
Abstract
Inflammatory bowel disease (IBD) may present with nonspecific symptoms and diagnostic findings. Therefore, many diseases may mimic the clinical symptoms, endoscopic findings, and histologic features of IBD. In this paper, we will review mimics of IBD, dividing the diseases that can imitate IBD into noninfectious and infectious causes. For each disease state, we will discuss the clinical symptoms and endoscopic and histologic features. Finally, we will discuss how to distinguish these distinct disorders from IBD.
Collapse
Affiliation(s)
- Raina Shivashankar
- Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA
| | | |
Collapse
|
7
|
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract and includes both Crohn's disease and ulcerative colitis. Patients with IBD often present with abdominal pain, diarrhea, and rectal bleeding but may also have a wide variety of other symptoms such as weight loss, fever, nausea, vomiting, and possibly obstruction. Given that the presentation of IBD is not specific, the differential diagnosis is broad and encompasses a wide spectrum of diseases, many of which can mimic and/or even coexist with IBD. It is important for physicians to differentiate symptoms due to refractory IBD from symptoms due to IBD mimics when a patient is not responding to standard IBD treatment. Many of the various IBD mimics include infectious etiologies (viral, bacterial, mycobacterial, fungal, protozoal, and helminthic infections), vascular causes, other immune causes including autoimmune etiologies, drug-induced processes, radiation-induced, and other etiologies such as small intestinal bacterial overgrowth, diverticulitis, and bile acid malabsorption. Thoughtful consideration and evaluation of these potential etiologies through patient history and physical examination, as well as appropriate tests, endoscopic evaluation, and cross-sectional imaging is required to evaluate any patient presenting with symptoms consistent with IBD.
Collapse
|